Delta to stock in-flight medical kits with Narcan |

Delta to stock in-flight medical kits with Narcan

Naloxone, which can reverse the effects of a drug overdose, is available in nasal spray that retails for $90 to $125. The applicator manufactured by Radnor-based Adapt Pharma is inserted in the nose and dispenses 0.1 milliliters of the drug.

Delta Air Lines plans to stock its on-board emergency medical kits with Narcan, which can reverse the effects of opioid overdose, starting this fall.

The Atlanta-based airline made the decision earlier this year, spokesman Michael Thomas said.

Narcan is a brand name of the medication naloxone. The Association of Flight Attendants has called for the Federal Aviation Administration to require airlines to stock naloxone on all commercial flights and to train flight attendants to administer it.

According to the Association of Flight Attendants, United, Frontier and Alaska have planes with enhanced emergency medical kits stocked with naloxone. But without it as a standard item in emergency medical kits, people will be “at a higher risk of death by overdose in the air than on the ground,” the union told the FAA.

Delta discussed its plans to stock Narcan after a Delta Air Lines passenger tweeted about a medical incident involving a passenger on a flight.

Association of Flight Attendants international president Sara Nelson responded via Twitter that flight attendants “are aviation’s first responders and we need the proper tools to respond and save lives.”

It’s not the first time the issue has come up. A December article in the medical trade magazine EMS World detailed an incident involving a medical emergency on a Delta flight from New Orleans to Atlanta. Two paramedics who happened to be on board treated a passenger in distress as best they could. Once the plane landed, first responders boarded the plane and successfully treated the passenger with Narcan, the EMS World article reported.

Categories: Business | Wire stories
TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.